Elevance Health (ELV) Receivables - Other (2009 - 2026)

Elevance Health (ELV) has 18 years of Receivables - Other data on file, last reported at $6.8 billion in Q2 2026.

• On a quarterly basis, Receivables - Other fell 5.38% year-over-year to $6.8 billion in Q2 2026; TTM through Jun 2026 was $6.8 billion, a 5.38% decrease from a year earlier, with the FY2025 full-year figure at $6.3 billion, up 4.84% from the prior year.
• Receivables - Other for Q2 2026 stood at $6.8 billion, up from $6.2 billion in the prior quarter.
• Over the last five years, Receivables - Other for ELV reached as high as $7.7 billion in Q3 2025 and fell as low as $3.3 billion in Q1 2022.
• Historically, Receivables - Other has averaged $5.5 billion across 5 years, with a median of $5.6 billion in 2023.
• Across the five-year window, Receivables - Other surged 186.53% in 2022 and slipped 6.22% in 2026, its largest moves.
• Year by year, Receivables - Other stood at $4.3 billion in 2022, then increased by 25.76% to $5.4 billion in 2023, then rose by 11.3% to $6.0 billion in 2024, then rose by 4.84% to $6.3 billion in 2025, then rose by 8.1% to $6.8 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $6.8 billion in Q2 2026, $6.2 billion in Q1 2026, and $6.3 billion in Q4 2025.